• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比卡鲁胺-泊洛沙姆F68固体分散体系统的研制与表征

Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.

作者信息

Sancheti P P, Vyas V M, Shah M, Karekar P, Pore Y V

机构信息

Department of Pharmaceutical Chemistry, Government College of Pharmacy, Karad, Maharashtra, India.

出版信息

Pharmazie. 2008 Aug;63(8):571-5.

PMID:18771004
Abstract

The objective of the present work was to improve the dissolution rate of a poorly water-soluble drug, bicalutamide, by a solid dispersion technique. The solid dispersion systems of bicalutamide were prepared with poloxamer F68 in 1:1, 1:3, and 1:5 ratios using the melting method. The interaction of drug with polymer was evaluated by TLC, FTIR, and powder XRD. The results of powder XRD showed a significant decrease in the crystallinity of drug in the binary systems of bicalutamide. All binary systems of bicalutamide showed faster dissolution than pure drug alone (p < 0.001). However, among all binary systems studied, 1:1 proportion of bicalutamide : poloxamer was found to be excellent for dissolution enhancement (DP30: 99.98% +/- 3.9) of bicalutamide. The higher ratios of poloxamer F68 (1:3 and 1:5) had retarded the release of drug from their corresponding binary systems which might be due to its gelling property in higher concentration.

摘要

本研究的目的是通过固体分散技术提高难溶性药物比卡鲁胺的溶出速率。采用熔融法,以泊洛沙姆F68为载体,按1:1、1:3和1:5的比例制备比卡鲁胺固体分散体系统。通过薄层色谱法(TLC)、傅里叶变换红外光谱法(FTIR)和粉末X射线衍射法(XRD)评估药物与聚合物之间的相互作用。粉末XRD结果显示,在比卡鲁胺二元体系中药物的结晶度显著降低。比卡鲁胺的所有二元体系的溶出速度均比单独的纯药物快(p < 0.001)。然而,在所有研究的二元体系中,发现比卡鲁胺与泊洛沙姆1:1的比例对提高比卡鲁胺的溶出效果极佳(DP30:99.98% +/- 3.9)。较高比例的泊洛沙姆F68(1:3和1:5)延缓了药物从其相应二元体系中的释放,这可能是由于其在高浓度下的胶凝特性所致。

相似文献

1
Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.比卡鲁胺-泊洛沙姆F68固体分散体系统的研制与表征
Pharmazie. 2008 Aug;63(8):571-5.
2
Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.比卡鲁胺-β-环糊精包合物的固态表征及溶解特性
Pharmazie. 2008 Apr;63(4):282-5.
3
Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.机械应力作用下含有比卡鲁胺的固体分散体的溶解增强。
Int J Pharm. 2018 May 5;542(1-2):18-26. doi: 10.1016/j.ijpharm.2018.02.040. Epub 2018 Feb 23.
4
Formation of bicalutamide nanodispersion for dissolution rate enhancement.形成比卡鲁胺纳米分散体以提高溶解速率。
Int J Pharm. 2011 Feb 14;404(1-2):257-63. doi: 10.1016/j.ijpharm.2010.11.015. Epub 2010 Nov 18.
5
Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407.他达拉非固体分散体与泊洛沙姆 407 的理化特性研究。
Acta Pharm. 2009 Dec;59(4):453-61. doi: 10.2478/v10007-009-0037-4.
6
Nanosized bicalutamide and its molecular structure in solvents.纳米尺寸的比卡鲁胺及其在溶剂中的分子结构。
Int J Pharm. 2009 Mar 31;370(1-2):175-80. doi: 10.1016/j.ijpharm.2008.11.025. Epub 2008 Dec 3.
7
Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.依折麦布基于表面活性剂的固体分散体的制备及物理化学表征
Pharmazie. 2009 Apr;64(4):227-31.
8
Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188.依托考昔与泊洛沙姆188固体分散体系统的物理化学研究
Pharm Dev Technol. 2009;14(4):373-9. doi: 10.1080/10837450802683974.
9
Liquid antisolvent precipitation process for solubility modulation of bicalutamide.液体抗溶剂沉淀法调节比卡鲁胺溶解度。
Acta Pharm. 2011 Dec;61(4):435-45. doi: 10.2478/v10007-011-0036-0.
10
Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.使用水溶性载体对难溶性药物的溶出度增强及药物释放的数学建模研究。
Eur J Pharm Biopharm. 2007 Jan;65(1):26-38. doi: 10.1016/j.ejpb.2006.07.007. Epub 2006 Jul 20.

引用本文的文献

1
Another Move towards Bicalutamide Dissolution and Permeability Improvement with Acetylated β-Cyclodextrin Solid Dispersion.乙酰化β-环糊精固体分散体助力比卡鲁胺溶出度与渗透性提升的又一进展。
Pharmaceutics. 2022 Jul 15;14(7):1472. doi: 10.3390/pharmaceutics14071472.
2
How Does the CO in Supercritical State Affect the Properties of Drug-Polymer Systems, Dissolution Performance and Characteristics of Tablets Containing Bicalutamide?超临界状态下的二氧化碳如何影响含比卡鲁胺的药物-聚合物体系的性质、溶出性能及片剂特性?
Materials (Basel). 2020 Jun 25;13(12):2848. doi: 10.3390/ma13122848.
3
The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods.
泊洛沙姆的自组装现象及其对通过溶剂法获得的固体分散体中难溶性药物溶出度的影响。
Pharmaceutics. 2019 Mar 19;11(3):130. doi: 10.3390/pharmaceutics11030130.